VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Wednesday, December 31, 2025
Stock Comparison
ASX Limited vs Edwards Lifesciences Corporation
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
ASX Limited
ASX · ASX
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Edwards Lifesciences Corporation
EW · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Edwards Lifesciences Corporation's moat claims, evidence, and risks.
View EW analysisComparison highlights
- Moat score gap: Edwards Lifesciences Corporation leads (82 / 100 vs 80 / 100 for ASX Limited).
- Segment focus: ASX Limited has 4 segments (31.5% in Markets); Edwards Lifesciences Corporation has 3 segments (75.5% in Transcatheter Aortic Valve Replacement (TAVR)).
- Primary market structure: Duopoly vs Oligopoly. Pricing power: Moderate vs Moderate.
- Moat breadth: ASX Limited has 4 moat types across 3 domains; Edwards Lifesciences Corporation has 6 across 3.
Primary market context
ASX Limited
Markets
Trading venues for Australian cash equities and exchange-traded derivatives (futures, options)
Australia
Brokers/market participants, proprietary trading firms, institutional investors
Market operator / trading venue
31.5%
Edwards Lifesciences Corporation
Transcatheter Aortic Valve Replacement (TAVR)
Transcatheter aortic valve replacement (TAVR) devices
Global
Hospitals and structural heart centers
Medical device manufacturer
75.5%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
ASX Limited strengths
Edwards Lifesciences Corporation strengths
Segment mix
ASX Limited segments
Full profile >Listings
Quasi-Monopoly
Markets
Duopoly
Technology & Data
Competitive
Securities & Payments
Monopoly
Edwards Lifesciences Corporation segments
Full profile >Transcatheter Aortic Valve Replacement (TAVR)
Oligopoly
Transcatheter Mitral and Tricuspid Therapies (TMTT)
Competitive
Surgical Structural Heart
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.